Bone Marrow and Hemopoiesis

Introduction

• Bone marrow is the body’s primary blood-forming organ, continuously producing and replenishing blood cells throughout life. Understanding hematopoiesis, marrow structure, and the developmental shifts in blood cell formation provides the foundation for diagnosing hematological disorders and maintaining normal physiological function.

Bone Marrow

• Bone marrow is the primary site of hemopoiesis after birth.
• Hemopoiesis is the continuous formation of blood cells required to maintain normal circulation. It adapts to increased demand during conditions such as hemorrhage and infection.
• During fetal life, blood cell formation occurs mainly in the liver and spleen.
• After birth, hemopoiesis shifts to red bone marrow within the medullary cavities.
• With age, red marrow is gradually replaced by fatty yellow marrow.
• In adults, active marrow is mainly located in vertebrae, ribs, sternum, pelvis, skull, and ends of long bones.
• Bone marrow contains precursor cells at various stages of development. It also stores mature cells before their release into circulation.
• All blood cells arise from hematopoietic stem cells, which are pluripotent. These stem cells sustain lifelong production of red cells, white cells, and platelets. They maintain blood cell homeostasis by continuous proliferation and differentiation.

Types of Bone Marrow

• Bone marrow is classified into red marrow, yellow marrow, and white marrow based on structure and function.

Red Marrow

• Red marrow is the active hematopoietic tissue responsible for blood cell formation. It contains numerous vascular sinuses that facilitate entry of newly formed cells into circulation.
• The supporting marrow stroma consists of connective tissue, reticular cells, and vascular networks.
• Hemopoiesis occurs in spaces between sinusoidal capillaries.
• The sinus wall is composed of endothelial cells, a basement membrane, and reticular cells.
• Reticular cells can differentiate into fat cells and support structural organization.
• Endothelial and stromal cells release cytokines that regulate hematopoiesis.
• Bone-forming cells are also present within the marrow environment.
• Various precursor cells, including blast cells and megakaryocytes, are found in marrow tissue.
• Red blood cells develop within specialized clusters called erythroid nests.
• At birth, red marrow is present in almost all bones.
• With increasing age, it is gradually replaced by yellow marrow, reducing hematopoietic activity.
• In adults, active marrow is mainly located in vertebrae, ribs, sternum, skull, and pelvic bones.

Yellow Marrow

• Yellow marrow contains fewer blood vessels and is rich in fat cells and fibro-fatty tissue. It is largely inactive in hemopoiesis under normal conditions.
• With age, hematopoietic tissue in long bones is replaced by adipose tissue.
• Fat progressively occupies a significant portion of marrow space in adults.
• Despite inactivity, yellow marrow can revert to red marrow during increased demand. This transformation occurs in conditions such as chronic anemia or prolonged blood loss.

White Marrow

• White marrow develops in elderly individuals due to degeneration of fatty marrow.
• Fat is replaced by gelatinous, mucoid material. This change reflects reduced marrow activity with aging.

Bone Marrow Examination

• Bone marrow examination is performed in complex hematological and malignant disorders for detailed evaluation. It assesses overall cellularity as normal, increased, or decreased.
• The myeloid–erythroid ratio is evaluated to detect imbalance in cell production. It examines erythropoiesis, myelopoiesis, and megakaryocyte activity.
• The number and morphology of lymphocytes and plasma cells are assessed. It helps detect abnormal cells, including metastatic cells and infectious organisms.
• Iron stores are evaluated using special staining techniques.

Indications for Bone Marrow Examination

• Bone marrow examination is indicated in unexplained or severe anemias, including aplastic and megaloblastic types. It helps diagnose leukemias and differentiate their types. It is useful in disorders such as multiple myeloma, agranulocytosis, and thrombocytopenia. It evaluates iron stores and marrow activity. It is also used in planning bone marrow transplantation.

Table 10.1: Differences between red and yellow bone marrow.

Feature	Red Marrow	Yellow Marrow
Activity	Hematopoietically active tissue	Functionally inactive under normal conditions
Cellularity	Highly cellular with diverse precursor cells	Low cellularity, rich in adipose tissue
Location	Axial skeleton and proximal ends of long bones	Predominantly in long bones outside active sites

Procedure

• Bone marrow examination is performed by aspiration or trephine biopsy. The procedure is done under local anesthesia using a sterile needle. A small sample of marrow is aspirated or a tissue core is obtained. The sample is processed and examined after appropriate staining.  Common stains include Romanowsky and May–Grünwald–Giemsa methods. Usual sites include the sternum, iliac crest, and vertebral spinous processes.

Bone Marrow Needle Aspiration

• Bone marrow aspiration is performed at specific anatomical sites for safe and effective sampling.
• Common sites include the sternum, iliac crest, and lumbar vertebral processes.

Sternal Puncture

• Sternal puncture is commonly used in adults, usually at the mid-manubrium.

Iliac Crest Puncture

• Iliac crest puncture is preferred in children and is also suitable for adults. It is performed at the posterior superior iliac spine for better access.

Vertebral Puncture

• Vertebral puncture is considered when sternal aspiration is contraindicated or unsuccessful.
• Selection of site depends on patient age, clinical condition, and safety considerations.

Bone Marrow Biopsy

• Bone marrow biopsy involves obtaining a core of tissue using a trephine needle. It is performed at the same sites as aspiration. The procedure provides detailed structural information but is more invasive and technically demanding.

Features of Marrow Smear

• Marrow smear examination evaluates overall cellularity and activity of hemopoiesis. It assesses erythropoiesis, leukopoiesis, and thrombopoiesis.
• The myeloid–erythroid ratio is determined for diagnostic purposes. It helps detect abnormal cells, tumor infiltration, plasma cell changes, and infectious organisms.

Cells in Bone Marrow

• Bone marrow contains hematopoietic cells at various stages of development. These include stem cells, colony-forming units, blast cells, and progenitor cells.
• Stem cells form a small fraction, about 0.5 percent of total marrow cells.
• The myeloid series, producing leukocytes, constitutes about seventy to seventy-five percent of cells.
• The erythroid series accounts for approximately twenty-five percent of marrow cells.
• The normal myeloid–erythroid ratio is about three to one. This ratio reflects balanced production of white and red blood cells.
• In peripheral blood, red cells greatly outnumber leukocytes, maintaining efficient oxygen transport and immune function.

Bone Marrow Transplantation

• Bone marrow transplantation involves collection and infusion of hematopoietic stem cells.
• Stem cells may be obtained from bone marrow or peripheral blood.
• Transplantation can be autologous or from a compatible donor. It restores normal blood cell production in diseased or damaged marrow.

Hemopoiesis

• Hemopoiesis is the process of formation, maturation, and release of blood cells. It ensures continuous replacement of cells that are regularly destroyed in circulation. This process maintains homeostasis of blood cell numbers and function. It is essential for sustaining normal physiological activity and survival.

Sites and Stages of Hemopoiesis

• Hemopoiesis occurs at different sites depending on developmental stage.
• In early fetal life, it begins in the yolk sac. It later shifts to the liver and spleen during intrauterine development.
• After birth, it is confined to the bone marrow. These sites provide a supportive microenvironment for cell formation.
• Hemopoiesis progresses through mesoblastic, hepatic, and medullary stages.

Mesoblastic Stage

• The mesoblastic stage occurs early in embryonic life, mainly in the yolk sac. It begins around the second week of gestation.
• Primitive stem cells with multilineage potential initiate early blood cell formation.
• Additional regions such as paraaortic and aorta–mesonephric areas also contribute stem cells.
• Early lymphoid precursors are present during this stage.

Hepatic Stage

• The hepatic stage occurs mainly during the second trimester of fetal life.
• The liver becomes the principal site of hemopoiesis from about the fifth week of gestation.
• Hemopoietic activity in the liver reaches its peak around the fifth month.
• The spleen also contributes, although to a lesser extent. Normally, hemopoiesis in these organs ceases after birth. Reactivation may occur under pathological conditions when marrow function is inadequate.

Medullary Stage

• The medullary stage involves blood cell formation in bone marrow. It begins during late fetal life when marrow cavities develop. Initially, granulocyte and platelet precursors are formed in marrow.
• Erythropoiesis becomes fully active in marrow during late gestation. After birth, bone marrow becomes the exclusive site of hemopoiesis.
• Hemopoiesis occurring outside marrow after birth is termed extramedullary hemopoiesis and indicates underlying pathology.

Rate of Medullary Hemopoiesis

• Bone marrow is a highly active organ responsible for continuous blood cell production. It produces about six billion cells per kilogram body weight each day. This includes red cells, platelets, and granulocytes in balanced proportions.
• The rate of production is regulated according to physiological demands.
• Increased requirements such as infection or blood loss stimulate enhanced cell production.

Sites of Medullary Hemopoiesis

• Bone marrow is the primary site of erythropoiesis after birth.
• In long bones, active marrow declines after the first decade of life.
• By early adulthood, these bones largely lose hematopoietic activity.
• Active marrow persists in vertebrae, ribs, sternum, skull, and pelvic girdle.
• Hemopoietic activity gradually decreases with advancing age.

Table 10.2: The different cell population in bone marrow and their rate of production in the marrow.

Cell Population	Approximate Marrow Count (per kg)	Daily Production (per kg)
Erythroid cells (erythroblasts, reticulocytes)	Moderate to high	Very high turnover (~3 × 10⁹)
Megakaryocytes	Low numbers	Moderate production
Granulocytes (proliferative and mitotic pools)	High reserves	Rapid renewal (~0.85 × 10⁹)

Table 10.3: Differences between stem cells and progenitor cells.

Feature	Stem Cells	Progenitor Cells
Proliferation	High capacity	Limited divisions
Self-renewal	Present	Absent
Differentiation	Multilineage potential	Restricted potential
Origin	Primitive cells	Derived from stem cells
Cytokine response	Strong	Reduced
Staining pattern	Dim fluorescence	Bright fluorescence

Steps of Hemopoiesis

• Hemopoiesis begins in bone marrow from hematopoietic stem cells.
• The primary cell is a pluripotent stem cell capable of self-renewal and differentiation. These cells give rise to two major lineages: myeloid and lymphoid.
• Lymphoid lineage produces lymphocytes responsible for immune functions.
• Myeloid lineage forms erythrocytes, granulocytes, monocytes, and platelets.
• Stem cells differentiate into progenitor cells with more restricted potential.
• Progenitor cells further mature into specific blood cell types. This process involves sequential stages of proliferation and differentiation.
• Proper regulation ensures balanced production of all circulating blood cells.

Stem Cells

Properties

• Stem cells in bone marrow possess self renewal and differentiation abilities.

Self Renewal

• Self renewal allows stem cells to divide and maintain a constant pool. This ensures a continuous supply of precursor cells throughout life. These cells do not get depleted under normal physiological conditions.

Differentiation

• Differentiation enables stem cells to develop into specific blood cell lineages.
• Through differentiation, they form progenitor cells with restricted potential. This process supports production of all circulating blood cells.

Types

• Two main types are myeloid stem cells and lymphoid stem cells.

Myeloid Stem Cells

• Myeloid stem cells are multipotent and generate several blood cell types. They give rise to erythroid cells, granulocytes, monocytes, and megakaryocytes.
• Granulocytes include neutrophils, eosinophils, and basophils.
• Megakaryocytes further produce platelets essential for clotting.

Lymphoid Stem Cells

• Lymphoid stem cells produce lymphocytes involved in immune responses. These cells are more lineage-restricted compared to myeloid stem cells.
• Proper balance between stem cell proliferation and differentiation is essential.
• Disturbances in these processes may lead to hematological disorders.

Progenitor Cells

• Progenitor cells arise from stem cells and have limited self-renewal capacity. They form colony forming units that generate specific blood cell lineages.
• A major precursor is CFU-GEMM, which gives rise to multiple myeloid lineages.
• CFU-E produces erythroid precursors leading to red blood cells.
• CFU-GM differentiates into granulocyte and monocyte lineages.
• Granulocyte precursors form neutrophils, eosinophils, and basophils.
• Monocyte precursors develop into circulating monocytes.
• CFU-Meg produces megakaryoblasts, which form platelets.
• Progenitor cells ensure efficient and regulated production of blood cells.

Types of Hemopoiesis

• Hemopoiesis is classified into erythropoiesis, leukopoiesis, and thrombopoiesis.
• Erythropoiesis involves formation of red blood cells from proerythroblasts.
• Leukopoiesis includes development of white blood cells for immune defense.
• Granulocytes arise from myeloblasts and include neutrophils, eosinophils, and basophils.
• Monocytes develop from monoblasts and participate in phagocytosis.
• Lymphocytes arise from lymphoblasts and mediate adaptive immunity.
• Thrombopoiesis involves formation of platelets from megakaryoblasts.
• Each lineage undergoes regulated stages of proliferation and maturation.

Table 10.4: Target cells of hemopoietic growth factors (HGFs).

Cell Lineage	Key Hemopoietic Growth Factors
Erythroid cells	Erythropoietin, interleukins, granulocyte–macrophage colony-stimulating factor
Neutrophils	Granulocyte colony-stimulating factor
Macrophages	Colony-stimulating factor-1, interleukins
Eosinophils	Interleukin-5, interleukin-3
Megakaryocytes	Multiple interleukins and growth factors
Lymphocytes	Interleukins regulating B and T cell development

Regulation of Hemopoiesis

• Hemopoiesis is regulated by cytokines known as hemopoietic growth factors. These factors control proliferation, differentiation, and maturation of blood cell precursors.
• Many growth factors act on multiple cell lineages, while some are lineage-specific.
• Erythropoietin, produced by the kidneys, stimulates red cell production during hypoxia.
• Interleukins regulate development of various blood cells.
• Specific interleukins influence eosinophils, lymphocytes, and monocyte–macrophage systems.
• Colony stimulating factors promote growth of precursor cells.
• Granulocyte colony-stimulating factor enhances granulocyte formation.
• Macrophage colony-stimulating factor supports monocyte and macrophage development.
• Granulocyte–macrophage colony-stimulating factor stimulates both granulocytes and monocytes. Other regulators include factors that influence megakaryocyte growth and lymphocyte differentiation. These regulatory mechanisms ensure balanced production of all blood cell types. Proper control maintains normal blood composition and supports immune and physiological functions.